Jacobs Levy Equity Management »

Prelude Therapeutics shares owned by Jacobs Levy Equity Management

Quarter-by-quarter ownership of Prelude Therapeutics (PRLD) shares owned by Jacobs Levy Equity Management from 13F filings

Historical chart of Jacobs Levy Equity Management investment in Prelude Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Prelude Therapeutics held by Jacobs Levy Equity Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prelude Therapeutics by Jacobs Levy Equity Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $561k 131k 4.27
2023-09-30 $445k 144k 3.09
2023-06-30 $524k 117k 4.50
2023-03-31 $483k 85k 5.70
2021-12-31 $1.6M 130k 12.45